Related Experiment Video
Updated: May 7, 2026

12:31
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
Published on: May 1, 2018
Phage display technology for human monoclonal antibodies
Cecilia Deantonio1, Diego Cotella, Paolo Macor
1Department of Health Sciences and Interdisciplinary Research Center for Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Novara, Italy.
Methods in Molecular Biology (Clifton, N.J.)
|September 17, 2013
Summary
Phage display technology enables rapid in vitro selection of high-affinity antibodies. This method allows for antibody engineering to enhance affinity, specificity, and effector functions for therapeutic applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Immunology
Background:
- In vitro technologies have advanced antibody discovery.
- Filamentous phage display is a common method for antibody library generation and selection.
- Antibodies (Abs) are displayed on phage surfaces by fusing variable (V) regions to phage minor coat protein pIII.
Purpose of the Study:
- To describe protocols for antibody library construction, handling, and selection using phage display.
- To highlight the capabilities of phage display for identifying lead candidates with high affinity.
Main Methods:
- Construction of large antibody libraries displayed on filamentous phage.
- Selection of antibodies through cycles of antigen binding.
- Engineering of selected antibody genes for improved characteristics.
Main Results:
- Antibodies with affinities comparable to hybridoma technology can be selected.
- Phage display allows for in-situ cloning and subsequent engineering of antibody genes.
- Engineered antibodies can exhibit enhanced affinity, modulated specificity, or altered effector functions.
Conclusions:
- Phage display is a powerful in vitro technology for antibody discovery and engineering.
- This method facilitates the generation of antibody libraries and rapid selection of desired antibody candidates.
- The technology enables optimization of antibody properties beyond natural immune system capabilities.

